Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01924182 · ClinicalTrials.gov registry record · NA
Intrathecal Morphine Compared to Conventional Medical Management for Pain Control and Opioid-related Side Effects
A NA study, sponsored by MedtronicNeuro.
- Terminated
- Registry status
- NA
- Development phase
- 7
- Enrollment target
NCT01924182: Clinical Trial NA study, sponsored by MedtronicNeuro.
NCT01924182 is a NA study that was terminated before completion, run by MedtronicNeuro. The registered enrollment target is 7 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01924182, a NA study, was terminated before completion, sponsored by MedtronicNeuro.
- TERMINATED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
Study Summary
This study compares two different ways to treat pain. The two ways are: 1. continuing to take current pain medication(s) or 2. receiving morphine, a pain medication from a drug pump (a system to deliver drug to your body) that is implanted. None of the procedures or products used in this study are experimental. The length the study will be about 25 weeks (between 5½ to 6½ months). The purpose of this study is to compare pain and opioid side effects between people who get a drug pump and people who do not get a drug pump that will stay on their current pain medication treatment.
Primary Outcome
Determine the proportion of subjects with clinical success based on changes in pain intensity (Numerical Pain Rating Scale: NPRS) and opioid-related Common Toxicity Criteria for Adverse Events (CTCAE) from the National Cancer Institute (NCI).
Interventions
- DEVICE SynchroMed Infusion System and Intrathecal Morphine Sulfate
- OTHER Conventional Medicine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2013-10 |
| Est. Completion | 2015-07 |
| Phase | NA |
Why NCT01924182 stopped before completion
NCT01924182 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 7 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 2 interventions - of which SynchroMed Infusion System and Intrathecal Morphine Sulfate is the first listed.
NCT01924182 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01924182 about?
NCT01924182 is a clinical study titled "Intrathecal Morphine Compared to Conventional Medical Management for Pain Control and Opioid-related Side Effects". This study compares two different ways to treat pain. The two ways are: 1. continuing to take current pain medication(s) or 2. receiving morphine, a pain medication from a drug pump (a system to deliver drug to your body) that is implanted. None of the procedures or products used in this study are...
What is the current status of trial NCT01924182?
This trial is currently terminated. It is a NA study. The enrollment target is 7 participants. The study started on 2013-10. Estimated completion is 2015-07.
What interventions are being tested in trial NCT01924182?
The interventions under investigation include: SynchroMed Infusion System and Intrathecal Morphine Sulfate (DEVICE), Conventional Medicine (OTHER).
Who is sponsoring clinical trial NCT01924182?
This trial is sponsored by MedtronicNeuro, which has 51 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01924182's enrollment target sits among peer trials
7 1982nd of 2000 higher than 18 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia